4,0
22. Okt. 2012
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good company, generally ethical and fair; tough and usually successful competitor in the medical device market. One of the now dwindling group of companies that still have a pension plan in addition to a 401K.
Kontras
Like so many older American firms it is becoming more and more difficult to turn a profit in the states, so success from plants overseas often results in production expansion and growth but not in the US operations. The company is large and diversified so raises are pretty consistent but usually just keep up with inflation and such.